David Riddell

4.8k total citations · 1 hit paper
43 papers, 2.6k citations indexed

About

David Riddell is a scholar working on Physiology, Molecular Biology and Surgery. According to data from OpenAlex, David Riddell has authored 43 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Physiology, 10 papers in Molecular Biology and 8 papers in Surgery. Recurrent topics in David Riddell's work include Alzheimer's disease research and treatments (14 papers), Computational Drug Discovery Methods (7 papers) and Cholinesterase and Neurodegenerative Diseases (5 papers). David Riddell is often cited by papers focused on Alzheimer's disease research and treatments (14 papers), Computational Drug Discovery Methods (7 papers) and Cholinesterase and Neurodegenerative Diseases (5 papers). David Riddell collaborates with scholars based in United Kingdom, United States and Canada. David Riddell's co-authors include James S. Owen, Colin Dingwall, Ishrut Hussain, Gary Christie, Annette Graham, Jill Richardson, Thomas A. Comery, Gary E. Landreth, Shweta Mandrekar and Timothy M. Willson and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Neuron.

In The Last Decade

David Riddell

43 papers receiving 2.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

ApoE Promotes the Proteolytic Degradation of Aβ

2008 716 citations Qingguang Jiang, Shweta Mandrekar et al. Neuron profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David Riddell United Kingdom	21	1.3k	998	489	451	319	43	2.6k
Thierry Pillot France	32	1.4k 1.1×	1.4k 1.4×	404 0.8×	422 0.9×	371 1.2×	57	2.8k
Suzana Petanceska United States	29	1.8k 1.4×	1.1k 1.1×	538 1.1×	435 1.0×	298 0.9×	43	3.2k
Chunjiang Yu United States	26	1.5k 1.2×	1.6k 1.6×	417 0.9×	519 1.2×	491 1.5×	46	3.5k
Wesley Farris United States	10	1.9k 1.5×	987 1.0×	209 0.4×	416 0.9×	414 1.3×	11	2.7k
Qingguang Jiang United States	9	1.2k 0.9×	806 0.8×	398 0.8×	366 0.8×	620 1.9×	9	2.1k
Paige E. Cramer United States	7	1.2k 0.9×	785 0.8×	290 0.6×	379 0.8×	490 1.5×	7	2.0k
Kun Zou Japan	26	1.2k 0.9×	1.2k 1.2×	248 0.5×	386 0.9×	339 1.1×	75	2.7k
Urule Igbavboa United States	29	1.2k 0.9×	1.6k 1.6×	715 1.5×	420 0.9×	133 0.4×	50	2.6k
Walter J. Brecht United States	14	1.1k 0.8×	852 0.9×	442 0.9×	311 0.7×	183 0.6×	22	2.0k
Henri J. Huttunen Finland	32	1.1k 0.8×	1.8k 1.8×	394 0.8×	599 1.3×	570 1.8×	62	4.0k

Countries citing papers authored by David Riddell

Since Specialization

Citations

This map shows the geographic impact of David Riddell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Riddell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Riddell more than expected).

Fields of papers citing papers by David Riddell

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Riddell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Riddell. The network helps show where David Riddell may publish in the future.

Co-authorship network of co-authors of David Riddell

This figure shows the co-authorship network connecting the top 25 collaborators of David Riddell. A scholar is included among the top collaborators of David Riddell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Riddell. David Riddell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zuhl, Andrea M., Charles E. Nolan, Michael A. Brodney, et al.. (2016). Chemoproteomic profiling reveals that cathepsin D off-target activity drives ocular toxicity of β-secretase inhibitors. Nature Communications. 7(1). 13042–13042. 59 indexed citations

Gonzales, Cathleen, Margaret M. Zaleska, David Riddell, et al.. (2014). Alternative method of oral administration by peanut butter pellet formulation results in target engagement of BACE1 and attenuation of gavage-induced stress responses in mice. Pharmacology Biochemistry and Behavior. 126. 28–35. 40 indexed citations

Hajós, Mihály, Elena Morozova, Chester J. Siok, et al.. (2013). Effects of the γ-secretase inhibitor semagacestat on hippocampal neuronal network oscillation. Frontiers in Pharmacology. 4. 72–72. 10 indexed citations

Feng, Jianlin, Tamás Kiss, Elie Needle, et al.. (2012). Age-dependent disruption in hippocampal theta oscillation in amyloid-β overproducing transgenic mice. Neurobiology of Aging. 33(7). 1481.e13–1481.e23. 69 indexed citations

Lu, Yasong, Hugh A. Barton, Louis Leung, et al.. (2012). Cerebrospinal Fluid β-Amyloid Turnover in the Mouse, Dog, Monkey and Human Evaluated by Systematic Quantitative Analyses. Neurodegenerative Diseases. 12(1). 36–50. 18 indexed citations

Lu, Yasong, Liming Zhang, Charles E. Nolan, et al.. (2011). Quantitative Pharmacokinetic/Pharmacodynamic Analyses Suggest That the 129/SVE Mouse Is a Suitable Preclinical Pharmacology Model for Identifying Small-Molecule γ-Secretase Inhibitors. Journal of Pharmacology and Experimental Therapeutics. 339(3). 922–934. 19 indexed citations

Shineman, Diana W., Guriqbal S. Basi, Jennifer L. Bizon, et al.. (2011). Accelerating drug discovery for Alzheimer's disease: best practices for preclinical animal studies. Alzheimer s Research & Therapy. 3(5). 28–28. 104 indexed citations

Belinsky, Martin G., Yuliya Skorobogatko, Lori Rink, et al.. (2009). High density DNA array analysis reveals distinct genomic profiles in a subset of gastrointestinal stromal tumors. Genes Chromosomes and Cancer. 48(10). 886–896. 33 indexed citations

Jiang, Qingguang, Shweta Mandrekar, Brandy Wilkinson, et al.. (2008). ApoE Promotes the Proteolytic Degradation of Aβ. Neuron. 58(5). 681–693. 716 indexed citations breakdown →

10.

Riddell, David, Hua Zhou, Kevin Atchison, et al.. (2008). Impact of Apolipoprotein E (ApoE) Polymorphism on Brain ApoE Levels. Journal of Neuroscience. 28(45). 11445–11453. 277 indexed citations

11.

Vinson, Mary, Oliver Rausch, Peter R. Maycox, et al.. (2003). Lipid rafts mediate the interaction between myelin-associated glycoprotein (MAG) on myelin and MAG-receptors on neurons. Molecular and Cellular Neuroscience. 22(3). 344–352. 77 indexed citations

12.

Tagalakis, Aristides D., Ian R. Graham, David Riddell, J.G. Dickson, & James S. Owen. (2001). Gene Correction of the Apolipoprotein (Apo) E2 Phenotype to Wild-type ApoE3 by in Situ Chimeraplasty. Journal of Biological Chemistry. 276(16). 13226–13230. 70 indexed citations

13.

Riddell, David, Gary Christie, Ishrut Hussain, & Colin Dingwall. (2001). Compartmentalization of β-secretase (Asp2) into low-buoyant density, noncaveolar lipid rafts. Current Biology. 11(16). 1288–1293. 259 indexed citations

14.

Riddell, David, et al.. (1999). Identification and characterization of LRP8 (apoER2) in human blood platelets. Journal of Lipid Research. 40(10). 1925–1930. 88 indexed citations

15.

Stannard, Anita K., David Riddell, Nicholas J. Bradley, et al.. (1998). Apolipoprotein E and regulation of cytokine-induced cell adhesion molecule expression in endothelial cells. Atherosclerosis. 139(1). 57–64. 18 indexed citations

16.

Riddell, David, Annette Graham, & James S. Owen. (1997). Apolipoprotein E Inhibits Platelet Aggregation through the L-Arginine:Nitric Oxide Pathway. Journal of Biological Chemistry. 272(1). 89–95. 170 indexed citations

17.

Riddell, David & James S. Owen. (1997). Nitric Oxide and Platelet Aggregation. Vitamins and hormones. 57. 25–48. 117 indexed citations

18.

Riddell, David & James S. Owen. (1996). Inhibition of ADP-induced platelet aggregation by apoE is not mediated by membrane cholesterol depletion. Thrombosis Research. 81(5). 597–606. 7 indexed citations

19.

Riddell, David & James S. Owen. (1995). Inhibition of ADP-induced platelet aggregation by apoE is not mediated by membrane cholesterol depletion. Thrombosis Research. 80(6). 499–508. 16 indexed citations

20.

Fenton, Garry, et al.. (1989). Hypolipidemic 2-[4-(1,1-dimethylethyl)phenyl]-4H-3,1-benzoxazin-4-ones. Structure-activity relationships of a novel series of high-density lipoprotein elevators. Journal of Medicinal Chemistry. 32(1). 265–272. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact